MK-4541

Cat. No.: IBDI-432289

MK-4541 is an orally active and selective androgen receptor (AR) modulator. MK-4541 acts as an antagonist to inhibit 5α-reductase. MK-4541 inhibits proliferation and induces apoptosis in AR positive prostate cancer cells. MK-4541 significantly inhibited the growth of R3327-G prostate tumors in xenograft mouse model.

Product Details

Target	Androgen Receptor | 5 alpha Reductase
Molecular Weight	428.49
SMILES	C[[email protected]@]12[[email protected]]3([H])[[email protected]](CC[[email protected]@]1([H])N(C(C=C2)=O)C)([H])[[email protected]@]4([H])[[email protected]@](C)([[email protected]@H](NC(OCC(F)(F)F)=O)CC4)CC3

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.